{"id":"provera-10-mg","safety":{"commonSideEffects":[{"rate":null,"effect":"Irregular bleeding or amenorrhea"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Mood changes"}]},"_chembl":{"chemblId":"CHEMBL5314922","moleculeType":"Small molecule","molecularWeight":"436.52"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Medroxyprogesterone acetate is a long-acting progestin that prevents pregnancy through multiple mechanisms: it thickens cervical mucus to impede sperm transport, alters the endometrium to prevent implantation, and most importantly, suppresses the luteinizing hormone (LH) surge required for ovulation. The 10 mg formulation is typically used for contraceptive or hormone replacement purposes.","oneSentence":"Provera (medroxyprogesterone acetate) is a synthetic progestin that suppresses gonadotropin secretion and inhibits ovulation by acting on the hypothalamic-pituitary-ovarian axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:39.650Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Hormone replacement therapy"},{"name":"Treatment of abnormal uterine bleeding"}]},"trialDetails":[{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT07319429","phase":"PHASE2, PHASE3","title":"Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-25","conditions":"Endometrial Cancer, Fertility","enrollment":260},{"nctId":"NCT07032506","phase":"NA","title":"Intrauterine Stent Placement Following Hysteroscopic Septum Resection","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-03","conditions":"Intrauterine Adhesion","enrollment":320},{"nctId":"NCT05452928","phase":"PHASE4","title":"Aciclovir Versus Placebo for HSV-2 Meningitis","status":"NOT_YET_RECRUITING","sponsor":"Jacob Bodilsen","startDate":"2026-06-01","conditions":"Herpes Simplex 2, Meningitis, Viral","enrollment":150},{"nctId":"NCT07020429","phase":"NA","title":"Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-09-01","conditions":"Premature Ovarian Insufficiency","enrollment":276},{"nctId":"NCT05651282","phase":"PHASE4","title":"Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2023-03-15","conditions":"Endometrium Cancer","enrollment":250},{"nctId":"NCT05255653","phase":"PHASE2, PHASE3","title":"Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2021-11-11","conditions":"Endometrial Cancer","enrollment":1615},{"nctId":"NCT06637189","phase":"PHASE4","title":"Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.","status":"NOT_YET_RECRUITING","sponsor":"Ginefiv","startDate":"2024-10-15","conditions":"Stimulation in the Ovary, Embryo, Oocyte","enrollment":144},{"nctId":"NCT02228681","phase":"PHASE2","title":"Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer","status":"COMPLETED","sponsor":"GOG Foundation","startDate":"2015-05-21","conditions":"Advanced, Persistent, or Recurrent Endometrial Cancer","enrollment":74},{"nctId":"NCT06304220","phase":"NA","title":"Comparison of Two PPOS Models for Pituitary Suppression","status":"NOT_YET_RECRUITING","sponsor":"NextFertility","startDate":"2024-07","conditions":"Infertility, Female, Fertility Disorders","enrollment":210},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT04414761","phase":"PHASE3","title":"Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-04","conditions":"IVF, GnRH Antagonist, PPOS","enrollment":784},{"nctId":"NCT04814927","phase":"PHASE4","title":"Impact of Contraceptives on Cervico-Vaginal Mucosa","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2021-03-01","conditions":"Mucosal Inflammation, Contraceptive; Complications, Intrauterine","enrollment":112},{"nctId":"NCT03675139","phase":"PHASE3","title":"MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia","status":"COMPLETED","sponsor":"Xiaojun Chen","startDate":"2019-02-26","conditions":"Endometrial Hyperplasia Without Atypia","enrollment":471},{"nctId":"NCT04021017","phase":"PHASE1","title":"PRE-GAiN Bone Health Pilot Study","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2020-01-21","conditions":"Anorexia Nervosa","enrollment":""},{"nctId":"NCT02449161","phase":"PHASE3","title":"The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates","status":"TERMINATED","sponsor":"Guy Waddell","startDate":"2015-08","conditions":"Menorrhagia","enrollment":60},{"nctId":"NCT02353247","phase":"NA","title":"Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant","status":"COMPLETED","sponsor":"Norton Healthcare","startDate":"2015-08","conditions":"Etonogestrel Contraceptive Implant, Bothersome Bleeding","enrollment":88},{"nctId":"NCT04887402","phase":"","title":"Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2021-01-01","conditions":"PCO, Induction of Ovulation, Clomiphene Citrate","enrollment":100},{"nctId":"NCT05138367","phase":"PHASE1","title":"Effects of UCA-PSCs in Women With POF","status":"COMPLETED","sponsor":"Li-jun Ding","startDate":"2018-12-01","conditions":"Premature Ovarian Failure","enrollment":20},{"nctId":"NCT00088153","phase":"PHASE2, PHASE3","title":"Effects of Anorexia Nervosa on Bone Mass in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-07","conditions":"Anorexia Nervosa","enrollment":110},{"nctId":"NCT03300960","phase":"PHASE3","title":"Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2017-10-20","conditions":"Infertility","enrollment":318},{"nctId":"NCT00997893","phase":"PHASE2","title":"Research Investigation of Soy and Estrogen","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2009-12","conditions":"Menopause, Hot Flashes","enrollment":96},{"nctId":"NCT04654741","phase":"PHASE4","title":"The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles","status":"UNKNOWN","sponsor":"Casa di Cura Privata Villa Mafalda","startDate":"2020-09-01","conditions":"IVF, Infertility","enrollment":396},{"nctId":"NCT01718444","phase":"NA","title":"Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)","status":"TERMINATED","sponsor":"University of Illinois at Chicago","startDate":"2015-03","conditions":"Polycystic Ovary Syndrome, Infertility","enrollment":27},{"nctId":"NCT02922348","phase":"PHASE3","title":"Hormone Replacement for Premature Ovarian Insufficiency","status":"WITHDRAWN","sponsor":"University of Pennsylvania","startDate":"2016-03-01","conditions":"Primary Ovarian Insufficiency","enrollment":""},{"nctId":"NCT01074892","phase":"PHASE4","title":"A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2005-05","conditions":"Endometrial Hyperplasia","enrollment":170},{"nctId":"NCT02792153","phase":"PHASE1","title":"Estradiol and Fear Extinction in Anorexia Nervosa (AN)","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2016-12","conditions":"Anorexia Nervosa","enrollment":""},{"nctId":"NCT02103764","phase":"PHASE3","title":"Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2013-08","conditions":"Dysfunctional Uterine Bleeding","enrollment":160},{"nctId":"NCT03309176","phase":"PHASE4","title":"\"Stair Step Study\"","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2016-06-21","conditions":"Ovulation Disorder","enrollment":42},{"nctId":"NCT02272647","phase":"PHASE1","title":"Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-12","conditions":"Healthy","enrollment":47},{"nctId":"NCT01008319","phase":"PHASE3","title":"Traditional Clomiphene Citrate Administration vs. Stair-step Approach","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2009-10","conditions":"Ovulatory Dysfunction, Anovulation, Ovulation Induction","enrollment":120},{"nctId":"NCT02855632","phase":"NA","title":"The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2016-08","conditions":"Intrauterine Adhesion","enrollment":240},{"nctId":"NCT02732808","phase":"PHASE3","title":"Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2014-09","conditions":"Infertility","enrollment":50},{"nctId":"NCT02064725","phase":"PHASE2","title":"Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA","status":"UNKNOWN","sponsor":"Kevelt AS","startDate":"2014-09","conditions":"Recurrent or Persistent Endometrial Carcinoma","enrollment":8},{"nctId":"NCT02872818","phase":"PHASE4","title":"Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kayseri Education and Research Hospital","startDate":"2014-10","conditions":"Apoptotic Signal Pathways in Endometrial Hyperplasia","enrollment":40},{"nctId":"NCT01011751","phase":"PHASE3","title":"Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma","status":"COMPLETED","sponsor":"Takeda","startDate":"2004-04","conditions":"Adenocarcinoma, Prostate","enrollment":311},{"nctId":"NCT01776203","phase":"PHASE4","title":"Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist","status":"TERMINATED","sponsor":"Kaiser Permanente","startDate":"2012-01","conditions":"Dysfunctional Uterine Bleeding","enrollment":8},{"nctId":"NCT01148420","phase":"PHASE4","title":"DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding","status":"COMPLETED","sponsor":"Women's Health Care Clinic, Torrance, California","startDate":"2009-01","conditions":"Dysfunctional Uterine Bleeding","enrollment":48},{"nctId":"NCT02024984","phase":"PHASE1","title":"Luteal Phase Versus Follicular Phase Administration of Clomiphene Citrate in PCOS, A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2013-11","conditions":"PCOS","enrollment":90},{"nctId":"NCT00490555","phase":"PHASE2, PHASE3","title":"PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT01953796","phase":"NA","title":"Clomiphene Stair-Step Protocol for Ovulation Induction in Women With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Kufa University","startDate":"2010-05","conditions":"Polycystic Ovary Syndrome","enrollment":140},{"nctId":"NCT00543634","phase":"PHASE1","title":"Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2007-10","conditions":"Postmenopause","enrollment":30},{"nctId":"NCT00191113","phase":"PHASE3","title":"Somatropin Treatment to Final Height in Turner Syndrome","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"1989-02","conditions":"Turner Syndrome","enrollment":154},{"nctId":"NCT00156650","phase":"PHASE1, PHASE2","title":"Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum","status":"COMPLETED","sponsor":"University of Washington","startDate":"2004-12","conditions":"Contraception","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Provera 10 mg.","genericName":"Provera 10 mg.","companyName":"Instituto Valenciano de Infertilidad, IVI VALENCIA","companyId":"instituto-valenciano-de-infertilidad-ivi-valencia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Provera 10 mg is a medication that contains the progestin medroxyprogesterone 17-acetate, which has been studied in clinical trials for various conditions including Polycystic Ovary Syndrome, Infertility, Dysfunctional Uterine Bleeding, Endometrial Cancer, and IVF. It is used as an intervention in fertility treatments, including those involving clomiphene citrate, to optimize fertility outcomes in women with Polycystic Ovary Syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}